Tiba Aynechi's most recent trade in MBX Biosciences Inc. was a trade of 16,000 Stock option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MBX Biosciences Inc. | Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 16,000 | 16,000 | - | - | Stock option (right to buy) | |
| MBX Biosciences Inc. | Tiba Aynechi | Director | 16 Sep 2024 | 16,666,666 | 0 | - | - | Series B Convertible Preferred Stock | ||
| MBX Biosciences Inc. | Tiba Aynechi | Director | 16 Sep 2024 | 1,386,335 | 1,386,335 | - | - | Common Stock | ||
| MBX Biosciences Inc. | Tiba Aynechi | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 750,000 | 2,136,335 | - | 16 | 12,000,000 | Common Stock |
| MBX Biosciences Inc. | Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Nkarta Inc | Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Spruce Biosciences Inc | Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) |